NCT03623581: Clinical Trial in Chinese Patients of Elapsed/Metastatic/Unresectable Alveolar Soft Part Sarcoma(GB226) |
|
|
| Recruiting | 2 | 35 | RoW | GB226, Recombinant humanized anti-PD-1 monoclonal antibody injection, Geptanolimab | Genor Biopharma Co., Ltd. | Alveolar Soft Part Sarcoma | 08/21 | 12/22 | | |